Quantcast

Latest Valeant Pharmaceuticals Stories

2014-09-15 16:29:11

LAVAL, Quebec, Sept. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX) today announced that its wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem all of the outstanding $500.0 million aggregate principal amount of its 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 (the "Notes") on October 15, 2014 and has mailed an irrevocable notice of redemption for the Notes. On September 15, 2014, a copy of the...

2014-09-09 08:33:05

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 9, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Teva Pharmaceutical Industries Limited (NYSE: TEVA), Universal Health Services Inc. (NYSE: UHS), Tenet Healthcare Corp. (NYSE: THC), Allergan Inc. (NYSE: AGN) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX). Private wealth members receive these notes ahead of publication. To reserve...

2014-09-08 16:25:58

Hosted Ribbon Cutting Ceremony for the New Bausch + Lomb ULTRA® Contact Lens Manufacturing Line and Solar Array Implementation LAVAL, Quebec, Sept. 8, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company hosted a ribbon cutting ceremony for the new Bausch + Lomb ULTRA® contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY. The ceremony recognized the expansion...

2014-09-02 12:25:09

With a fast growing multicultural healthcare practice, New York- and Denver-based XL Alliance looks to win award with its Hispanic campaign for calamine lotion Caladryl® NEW YORK, Sept. 2, 2014 /PRNewswire/ -- XL Alliance, an independent agency with a management team of former corporate clients and recognized healthcare experts, was announced as a finalist for the Medical Marketing & Media (MM&M) Awards in the category of "Best Multicultural Campaign." The MM&M Awards...

2014-08-25 08:28:25

SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Thesan Pharmaceuticals announced today the appointment of Bhaskar Chaudhuri Ph.D., to its Board of Directors. Dr. Chaudhuri has more than 25 years of experience in pharmaceuticals management, drug research & development, and commercialization in the US, EU and emerging markets. He has led the development and FDA approval of multiple NDAs and ANDAs. Most recently, Dr. Chaudhuri served as President of Valeant Pharmaceuticals before becoming...

2014-08-22 08:23:54

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, August 22, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP), Allergan, Inc. (NYSE: AGN), Valeant Pharmaceuticals Intl Inc. (NYSE: VRX), HCA Holdings Inc. (NYSE: HCA) and Puma Biotechnology Inc. (NYSE: PBYI). Private wealth members receive these notes ahead of publication. To reserve complementary membership,...

2014-08-15 16:24:18

LAVAL, Quebec, Aug. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan, Inc. ("Allergan") (NYSE: AGN) to 5:00 p.m., New York City time, on December 31, 2014. The exchange offer was previously scheduled to expire at 5:00 p.m., New York City time today, Friday, August 15, 2014. All other terms and conditions of the exchange offer...

2014-08-11 20:24:49

QUEBEC, Aug. 11, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) announced that the Company has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN). The information request was issued under notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The effect of the second request is to...

2014-08-11 08:27:52

CHESTERBROOK, Pa., Aug. 11, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, announced that Andrew Saik will be appointed Chief Financial Officer, effective August 18, 2014. Mr. Saik will be responsible for all financial and information technology activities and relationships and will play a critical leadership role in executing Auxilium's diversification and growth strategy. "Andrew brings nearly 20 years...

2014-08-06 16:28:46

ISS Raises Significant Concerns about Corporate Governance Practices at Allergan LAVAL, Quebec and NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX: VRX) and Pershing Square Capital Management, L.P. ("Pershing Square") today commented on Institutional Shareholder Services' ("ISS") recommendation in support of Pershing Square's effort to call a special meeting of Allergan shareholders. Pershing Square is seeking to call a special...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related